Evidence-Based Medicine Guidelines
Rituximab for rheumatoid arthritis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rituximab for Rheumatoid Arthritis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458367/all/Rituximab_for_rheumatoid_arthritis.
Rituximab for rheumatoid arthritis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/458367/all/Rituximab_for_rheumatoid_arthritis. Accessed November 22, 2024.
Rituximab for rheumatoid arthritis. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/458367/all/Rituximab_for_rheumatoid_arthritis
Rituximab for Rheumatoid Arthritis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458367/all/Rituximab_for_rheumatoid_arthritis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rituximab for rheumatoid arthritis
ID - 458367
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458367/all/Rituximab_for_rheumatoid_arthritis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
